SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (2903)8/8/2007 6:58:14 PM
From: Mike K   of 3044
 
Unfortunately, the Cowen analyst fails to understand that myeloma is a disease for which there is no cure. Celgene"s Revlimid and
Millenium's Velcade are both used throughout the course of treatment by many patients.

Revlimid is often preferred because it is oral. It is the treatment that I have chosen after my relapse last fall and I am
having great success. That said, I know several patients who
have relapsed after taking Revlimid and are now having good results with Velcade.

Certainly patients don't view these products as being competition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext